Genetic modifiers and ascertainment drive variable expressivity of complex disorders
Author:
Jensen MatthewORCID, Smolen CorrineORCID, Tyryshkina AnastasiaORCID, Pizzo LucillaORCID, Banerjee DeeproORCID, Oetjens MatthewORCID, Shimelis HermelaORCID, Taylor Cora M.ORCID, Pounraja Vijay KumarORCID, Song HyebinORCID, Rohan Laura, Huber EmilyORCID, El Khattabi LailaORCID, van de Laar IngridORCID, Tadros RafikORCID, Bezzina ConnieORCID, van Slegtenhorst Marjon, Kammeraad JannekeORCID, Prontera PaoloORCID, Caberg Jean-HubertORCID, Fraser HarryORCID, Banka Siddhartha, Van Dijck AnkeORCID, Schwartz Charles, Voorhoeve ElsORCID, Callier PatrickORCID, Mosca-Boidron Anne-LaureORCID, Marle NathalieORCID, Lefebvre MathildeORCID, Pope KateORCID, Snell PennyORCID, Boys AmberORCID, Lockhart Paul J.ORCID, Ashfaq MylaORCID, McCready ElizabethORCID, Nowacyzk Margaret, Castiglia LuciaORCID, Galesi OrnellaORCID, Avola EmanuelaORCID, Mattina TeresaORCID, Fichera MarcoORCID, Bruccheri Maria Grazia, Mandarà Giuseppa Maria LuanaORCID, Mari FrancescaORCID, Privitera FlaviaORCID, Longo IlariaORCID, Curró AuroraORCID, Renieri AlessandraORCID, Keren BorisORCID, Charles PerrineORCID, Cuinat SilvestreORCID, Nizon MathildeORCID, Pichon OlivierORCID, Bénéteau ClaireORCID, Stoeva RadkaORCID, Martin-Coignard Dominique, Blesson Sophia, Le Caignec CedricORCID, Mercier SandraORCID, Vincent MarieORCID, Martin ChristaORCID, Mannik KatrinORCID, Reymond AlexandreORCID, Faivre LaurenceORCID, Sistermans ErikORCID, Kooy R. FrankORCID, Amor David J.ORCID, Romano CorradoORCID, Andrieux Joris, Girirajan SanthoshORCID
Abstract
SUMMARYVariable expressivity of disease-associated variants implies a role for secondary variants that modify clinical features. We assessed the effects of modifier variants towards clinical outcomes of 2,252 individuals with primary variants. Among 132 families with the 16p12.1 deletion, distinct rare and common variant classes conferred risk for specific developmental features, including short tandem repeats for neurological defects and SNVs for microcephaly, while additional disease-associated variants conferred multiple genetic diagnoses. Within disease and population cohorts of 773 individuals with the 16p12.1 deletion, we found opposing effects of secondary variants towards clinical features across ascertainments. Additional analysis of 1,479 probands with other primary variants, such as 16p11.2 deletion andCHD8variants, and 1,084 without primary variants, showed that phenotypic associations differed by primary variant context and were influenced by synergistic interactions between primary and secondary variants. Our study provides a paradigm to dissect the genomic architecture of complex disorders towards personalized treatment.
Publisher
Cold Spring Harbor Laboratory
|
|